Rogatien Charlet Selected Research

GSK 1370319A

12/2020

Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rogatien Charlet Research Topics

Disease

7	Colitis 12/2020 - 01/2018
5	Inflammation (Inflammations) 12/2020 - 01/2018
1	Fibrosis (Cirrhosis) 01/2021
1	Immune System Diseases (Immune Disorders) 12/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2020
1	Body Weight (Weight, Body) 03/2019
1	Infections 01/2016

Drug/Important Bio-Agent (IBA)

3	Dextran SulfateIBA 01/2021 - 01/2018
2	GlucansIBA 01/2018 - 01/2016
1	CollagenIBA 01/2021
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 12/2020
1	Purinergic P2X7 ReceptorsIBA 12/2020
1	YO-PRO 1IBA 12/2020
1	GSK 1370319AIBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2020
1	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 12/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	SodiumIBA 01/2019
1	ChitinIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018

Therapy/Procedure

2	Oral Administration 01/2020 - 01/2018
1	Therapeutics 03/2019